Product Ref: SBRIS07 Category: R
Royal Mail Tracked 24 (Signed For)
Royal Mail Special Delivery Guaranteed by 1pm
Category | POM-V |
Temperature | Refrigerated |
MA/VM/EU No: | 42058/4124 |
Species |
|
VMD Link | https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_122287.PDF |
NOAH Link | |
Dosage | Reconstitute the vaccine by adding the liquid fraction to the freeze dried vial containing the lyophilised plug. When the lyophilised plug and liquid fraction are in equally sized vials: •Inject the entire liquid fraction into the freeze dried vial. When the lyophilised plug is in a smaller sized vial than the liquid fraction, the reconstitution of the vaccine is carried out in 2 steps: •Inject 10ml of the liquid fraction on the lyophilised plug in the freeze dried vial. •Shake well and extract the part reconstituted vaccine from the freeze dried vial and mix with the remaining liquid in the liquid fraction vial. Shake well before use. Vaccination Programme For cattle from 12 weeks of age two doses of 4 ml of reconstituted vaccine should be given three to four weeks apart, via the intramuscular route. Animals should preferably be vaccinated at least 3 weeks before a period of stress or high infection risk like re-grouping, transport of animals or the start of the autumn season. If ongoing protection against BRSV and BVDV Type 1 is required, then animals should be re-vaccinated after 6 months. |
Withdrawals | Vaccinate healthy animals only. The safety and efficacy of the veterinary medicinal product has not been established during pregnancy and lactation. Do not use during pregnancy and lactation. Transient and mild hyperthermia which can last for 2 days and a transient, minor local inflammation reaction of up to 0.5cm which disappears within 15 days can occur very commonly after administration of the vaccine. Very rarely, the vaccine may cause hypersensitivity reactions. In case of anaphylactic reaction, symptomatic treatment should be provided. The frequency of adverse reactions is defined using the following convention: -very common (more than 1 in 10 animals treated displaying adverse reaction(s)) -common (more than 1 but less than 10 animals in 100 animals treated) -uncommon (more than 1 but less than 10 animals in 1,000 animals treated) -rare (more than 1 but less than 10 animals in 10,000 animals treated) -very rare (less than 1 animal in 10,000 animals treated, including isolated reports). No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be decided on a case by case basis. Do not mix with any other veterinary medicinal product, except the solvent recommended for use with the veterinary medicinal product. Operator warnings In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. Withdrawal periods Zero days. |